In this review article find out which treatment plan is most appropriate for different groups of acute lymphoblastic leukemia patients.
Browsing: cancer management
Explore the current issues facing the management of DCIS and potential theraputic options in this review from Breast Cancer Management.
Recent research demonstrates that the ratio of abdominal fat to peripheral fat is a significant independent predictor of cancer.
What differing considerations should be taken into account when treating Adolescents and Young Adults (AYA) cancer patients compared to adult cancer patients? Discover in our interview with Sue Morgan MBE, Teenage Cancer Trust Nurse Consultant.
This report outlines the clinically led development of UK-focused guidance to challenge psycho-oncology services to achieve and demonstrate their potential.
To mark our focus on social media in cancer care we recently spoke with Deanna Attai from the University of California (CA, USA) about the potential use of social media in cancer care including how oncologists can incorporate social media into their care plans as well as the opportunities and risks they should be aware of
How teenagers continue school after a diagnosis of cancer: experiences of young people and recommendations for practice
In this research article from Future Oncology find out about recommendations for practice to support teenagers continuing school after a diagnosis of cancer.
Radioembolization for hepatocellular carcinoma: current role and future directions – the medical oncologist’s perspective
This article reviews yttrium-90 radioembolization of hepatocellular carcinoma from a clinical perspective, considering safety and efficacy, patient selection, and optimal assessment and management of patients.
Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?
How have transarterial therapies for hepatocellular carcinoma evolved over recent years? What impact have these changes had on patient outcomes? Read more in our partner journal Hepatic Oncology.
Following the continuing evolution of cancer immunotherapy, this featured article discusses how image-guided, minimally invasive therapies and immuno-oncology agents may be combined – could there be resultant synergy between these two modalities?